Halozyme Therapeutics
HALO
#2108
Rank
NZ$15.87 B
Marketcap
NZ$134.97
Share price
3.58%
Change (1 day)
32.20%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$15.87 Billion

As of February 2026 Halozyme Therapeutics has a market cap of NZ$15.87 Billion. This makes Halozyme Therapeutics the world's 2108th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$15.87 B13.5%
2025NZ$13.98 B28.79%
2024NZ$10.85 B40.64%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.21%
2021NZ$8.28 B3.58%
2020NZ$8.00 B122.33%
2019NZ$3.59 B14.02%
2018NZ$3.15 B-22.27%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.08%
2015NZ$3.24 B109.56%
2014NZ$1.54 B-25.89%
2013NZ$2.08 B127.26%
2012NZ$0.91 B-27.24%
2011NZ$1.26 B22.37%
2010NZ$1.03 B39.35%
2009NZ$0.74 B-5.72%
2008NZ$0.78 B8.69%
2007NZ$0.72 B-7.93%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of Halozyme Therapeutics was reported to be:

NZ$15.87 Billion
by Nasdaq info icon info icon
NZ$15.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$960.74 B 5,953.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$257.15 B 1,520.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.576 T 9,830.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$193.03 B 1,116.17%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ$18.56 B 16.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$2.94 B-81.42%๐Ÿ‡บ๐Ÿ‡ธ USA